Page last updated: 2024-09-04

isradipine, (s)-isomer and bosentan anhydrous

isradipine, (s)-isomer has been researched along with bosentan anhydrous in 1 studies

Compound Research Comparison

Studies
(isradipine, (s)-isomer)
Trials
(isradipine, (s)-isomer)
Recent Studies (post-2010)
(isradipine, (s)-isomer)
Studies
(bosentan anhydrous)
Trials
(bosentan anhydrous)
Recent Studies (post-2010) (bosentan anhydrous)
6011,836215630

Protein Interaction Comparison

ProteinTaxonomyisradipine, (s)-isomer (IC50)bosentan anhydrous (IC50)
Endothelin receptor type BRattus norvegicus (Norway rat)0.095
Endothelin receptor type BHomo sapiens (human)0.3044
Endothelin-1 receptorHomo sapiens (human)0.2317
Endothelin-1 receptorRattus norvegicus (Norway rat)0.0047
Endothelin-1 receptorSus scrofa (pig)0.0075

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1

Other Studies

1 other study(ies) available for isradipine, (s)-isomer and bosentan anhydrous

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007